IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Anti-Cancer Agents in Medicinal Chemistry

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

2.98

h-Index

2024-2025

 113

Rank

2024-2025

 10347

SJR

2024-2025

 0.562

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Anti-Cancer Agents in Medicinal Chemistry
Abbreviation Anti-Cancer Agents Med. Chem.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q3); Molecular Medicine (Q3); Pharmacology (Q3)
h-index 113
Overall Rank/Ranking 10347
SCImago Journal Rank (SJR) 0.562
Impact Score 2.98
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 18715206, 18755992
Best Quartile Q3
Coverage History 2006-2025




About Anti-Cancer Agents in Medicinal Chemistry


Anti-Cancer Agents in Medicinal Chemistry is a journal covering the technologies/fields/categories related to Cancer Research (Q3); Molecular Medicine (Q3); Pharmacology (Q3). It is published by Bentham Science Publishers. The overall rank of Anti-Cancer Agents in Medicinal Chemistry is 10347. According to SCImago Journal Rank (SJR), this journal is ranked 0.562. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 113. The best quartile for this journal is Q3.

The ISSN of Anti-Cancer Agents in Medicinal Chemistry journal is 18715206, 18755992. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Anti-Cancer Agents in Medicinal Chemistry is cited by a total of 2052 articles during the last 3 years (Preceding 2024).


Anti-Cancer Agents in Medicinal Chemistry Impact IF 2024-2025


The Impact IF 2024 of Anti-Cancer Agents in Medicinal Chemistry is 2.98, which is computed in 2025 as per its definition. Anti-Cancer Agents in Medicinal Chemistry IF is increased by a factor of 0.29 and approximate percentage change is 10.78% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Anti-Cancer Agents in Medicinal Chemistry Impact IF 2025 Prediction


Impact IF 2024 of Anti-Cancer Agents in Medicinal Chemistry is 2.98. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Anti-Cancer Agents in Medicinal Chemistry. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 2.98
2023 2.69
2022 2.77
2021 2.21
2020 2.27
2019 1.96
2018 1.92
2017 2.03
2016 2.42
2015 2.91
2014 2.65

Anti-Cancer Agents in Medicinal Chemistry h-index


  Table Setting

Anti-Cancer Agents in Medicinal Chemistry has an h-index of 113. It means 113 articles of this journal have more than 113 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Anti-Cancer Agents in Medicinal Chemistry ISSN


The ISSN of Anti-Cancer Agents in Medicinal Chemistry is 18715206, 18755992. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Anti-Cancer Agents in Medicinal Chemistry Rank and SCImago Journal Rank (SJR)


The overall rank of Anti-Cancer Agents in Medicinal Chemistry is 10347. According to SCImago Journal Rank (SJR), this journal is ranked 0.562. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Anti-Cancer Agents in Medicinal Chemistry by Year


Year SJR
2025/2026 Coming Soon
2024 0.562
2023 0.503
2022 0.428
2021 0.403
2020 0.508
2019 0.543
2018 0.528
2017 0.674
2016 0.807
2015 0.978
2014 0.963

Ranking of Anti-Cancer Agents in Medicinal Chemistry by Year


Year Ranking
2025/2026 Coming Soon
2024 10347
2023 10726
2022 11841
2021 12000
2020 9941
2019 9114
2018 9079
2017 7018
2016 5789
2015 4571
2014 4567

Anti-Cancer Agents in Medicinal Chemistry Publisher


Table Setting

Anti-Cancer Agents in Medicinal Chemistry is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Anti-Cancer Agents in Medicinal Chemistry is Anti-Cancer Agents Med. Chem.. This abbreviation ('Anti-Cancer Agents Med. Chem.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Anti-Cancer Agents in Medicinal Chemistry


If your research field is/are related to Cancer Research (Q3); Molecular Medicine (Q3); Pharmacology (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Anti-Cancer Agents in Medicinal Chemistry?

Anti-Cancer Agents in Medicinal Chemistry latest impact IF is 2.98. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.98 (2024) and 1.92 (2018), respectively, in the last 11 years. Moreover, its average IS is 2.44 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Anti-Cancer Agents in Medicinal Chemistry?

The Anti-Cancer Agents in Medicinal Chemistry has an SJR (SCImago Journal Rank) of 0.562, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.978 in 2015 and the lowest being 0.403 in 2021. Furthermore, the average SJR of the Anti-Cancer Agents in Medicinal Chemistry over the previous 11-year period stands at 2.44.


What's the latest h-index of the Anti-Cancer Agents in Medicinal Chemistry?

The latest h-index of the Anti-Cancer Agents in Medicinal Chemistry is 113.


Who's the publisher of the Anti-Cancer Agents in Medicinal Chemistry?

The Anti-Cancer Agents in Medicinal Chemistry is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.


What's the current ranking of the Anti-Cancer Agents in Medicinal Chemistry?

The Anti-Cancer Agents in Medicinal Chemistry is currently ranked 10347 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 4567 in 2014 and its lowest position of 12000 in 2021.


What's the abbreviation or short name for the Anti-Cancer Agents in Medicinal Chemistry?

The standard ISO4 abbreviation for the Anti-Cancer Agents in Medicinal Chemistry is Anti-Cancer Agents Med. Chem..


Is the "Anti-Cancer Agents in Medicinal Chemistry" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Anti-Cancer Agents in Medicinal Chemistry is classified as a journal that the Bentham Science Publishers publishes.


What's the scope or major areas of the Anti-Cancer Agents in Medicinal Chemistry?

The Anti-Cancer Agents in Medicinal Chemistry encompasses the following areas:

  • Cancer Research
  • Molecular Medicine
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Anti-Cancer Agents in Medicinal Chemistry?

The Anti-Cancer Agents in Medicinal Chemistry is assigned the following International Standard Serial Numbers (ISSN): 18715206, 18755992.


What's the best quartile of the Anti-Cancer Agents in Medicinal Chemistry?

The best quartile for the Anti-Cancer Agents in Medicinal Chemistry is Q3 (2024).


What's the coverage history of the Anti-Cancer Agents in Medicinal Chemistry?

The Anti-Cancer Agents in Medicinal Chemistry coverage history can be summarized as follows: 2006-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Journal of Geriatric Physical Therapy journal 8686 Lippincott Williams and Wilkins Ltd. 53 1.55
Journal of Education and Work journal 8987 Brill Academic Publishers 47 2.08
International Journal of Research and Method in Education journal 6367 Taylor and Francis Ltd. 41 3.31
Syntax journal 2676 Wiley-Blackwell Publishing Ltd 35 1.10
European Surgery - Acta Chirurgica Austriaca journal 18136 Springer Medizin 25 0.68
Indian Phytopathology journal 16772 Springer 20 0.91
Canadian Journal of Mathematics journal 7806 Canadian Mathematical Society 48 0.98
International Journal of Ozone Therapy journal 26290 Centauro SRL 6 0.00
Integrative Psychological and Behavioral Science journal 12203 Springer New York 44 1.59

Check complete list




Year wise Impact Score (IS) of Anti-Cancer Agents in Medicinal Chemistry

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 2.98
2023 2.69
2022 2.77
2021 2.21
2020 2.27
2019 1.96
2018 1.92
2017 2.03
2016 2.42
2015 2.91
2014 2.65



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Research | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Experimental and Molecular Medicine
Springer Nature | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

EMBO Molecular Medicine
Springer Science and Business Media Deutschland GmbH | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All